Autophagy-inhibitor mefloquine was shown to enhance nelfinavir-mediated cytotoxicity in breast cancer (MCF7), colon cancer (HCT116), lung cancer (NCI-H460), and Tsc2−/− cells. The gene discussed is TSC2; the disease is lung carcinoma.